WVE

Recent stories

• +8

  GSK selects Wave's siRNA program for further development.

  1 source·30/09, 11:42·finviz.com

• +7

  Company raises $402.5 million through public offering.

  1 source·11/12, 11:08·sec.gov

• +8

  Positive interim data from obesity trial announced.

  1 source·08/12, 12:40·sec.gov

• 0

  Corporate presentation update shared with investors.

  1 source·17/11, 12:32·sec.gov

• 0

  10-Q form submitted!

  1 source·10/11, 12:48·sec.gov

• 0

  Routine 8-K filing with no significant news.

  1 source·10/11, 12:36·sec.gov

• +5

  Positive trial data shared in investor webcast.

  1 source·30/10, 10:10·sec.gov

• +7

  Positive data for WVE-007 in obesity trial.

  1 source·29/10, 21:24·sec.gov

• 0

  Updated corporate presentation and investor disclosures.

  1 source·24/09, 12:34·sec.gov

• +8

  Positive Phase 1b/2a study results for WVE-006.

  1 source·03/09, 11:42·sec.gov